Oncotarget

Research Papers:

The dynamics of gene expression changes in a mouse model of oral tumorigenesis may help refine prevention and treatment strategies in patients with oral cancer

Jean-Philippe Foy _, Antonin Tortereau, Carlos Caulin, Vincent Le Texier, Emilie Lavergne, Emilie Thomas, Sylvie Chabaud, David Perol, Joël Lachuer, Wenhua Lang, Waun Ki Hong, Patrick Goudot, Scott M. Lippman, Chloé Bertolus and Pierre Saintigny

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2016; 7:35932-35945. https://doi.org/10.18632/oncotarget.8321

Metrics: PDF 1685 views  |   HTML 2616 views  |   ?  


Abstract

Jean-Philippe Foy1,2,3, Antonin Tortereau4, Carlos Caulin5, Vincent Le Texier6, Emilie Lavergne7, Emilie Thomas6, Sylvie Chabaud7, David Perol7, Joël Lachuer1,2,8,9, Wenhua Lang10, Waun Ki Hong11, Patrick Goudot3, Scott M Lippman12, Chloé Bertolus3, Pierre Saintigny1,2,13,14

1INSERM U1052, Cancer Research Center of Lyon, Lyon, France

2CNRS UMR 5286, Cancer Research Center of Lyon, Lyon, France

3Department of Oral and Maxillofacial Surgery, University of Pierre Marie Curie-Paris 6, Pitié-Salpêtrière Hospital, Paris, France

4Université de Lyon, VetAgro Sup, UPSP 2011-03-101, ICE, Marcy-l’Étoile, France

5Head and Neck Surgery at The University of Texas MD Anderson Cancer Center, Houston, TX, USA

6Department of Bioinformatics, Centre Léon Bérard, Lyon, France

7Department of Biostatistics, Centre Léon Bérard, Lyon, France

8Université Lyon 1, Université de Lyon, Lyon, France

9ProfileXpert, SFR-Est, CNRS UMR-S3453, INSERM US7, Lyon, France

10Thoracic/Head and Neck Medical Oncology at The University of Texas MD Anderson Cancer Center, Houston, TX, USA

11Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center, Houston, TX, USA

12UC San Diego Moores Cancer Center, La Jolla, CA, USA

13Departments of Medicine and Translational Research and Innovation, Centre Leon Berard, Lyon, France

14Centre Léon Bérard, Lyon, France

Correspondence to:

Pierre Saintigny, email: [email protected]

Keywords: oral preneoplasia, tumorigenesis, prevention, oral cancer, genome-wide expression profiles

Received: December 03, 2015     Accepted: March 06, 2016     Published: March 24, 2016

ABSTRACT

A better understanding of the dynamics of molecular changes occurring during the early stages of oral tumorigenesis may help refine prevention and treatment strategies. We generated genome-wide expression profiles of microdissected normal mucosa, hyperplasia, dysplasia and tumors derived from the 4-NQO mouse model of oral tumorigenesis. Genes differentially expressed between tumor and normal mucosa defined the “tumor gene set” (TGS), including 4 non-overlapping gene subsets that characterize the dynamics of gene expression changes through different stages of disease progression. The majority of gene expression changes occurred early or progressively. The relevance of these mouse gene sets to human disease was tested in multiple datasets including the TCGA and the Genomics of Drug Sensitivity in Cancer project. The TGS was able to discriminate oral squamous cell carcinoma (OSCC) from normal oral mucosa in 3 independent datasets. The OSCC samples enriched in the mouse TGS displayed high frequency of CASP8 mutations, 11q13.3 amplifications and low frequency of PIK3CA mutations. Early changes observed in the 4-NQO model were associated with a trend toward a shorter oral cancer-free survival in patients with oral preneoplasia that was not seen in multivariate analysis. Progressive changes observed in the 4-NQO model were associated with an increased sensitivity to 4 different MEK inhibitors in a panel of 51 squamous cell carcinoma cell lines of the aerodigestive tract. In conclusion, the dynamics of molecular changes in the 4-NQO model reveal that MEK inhibition may be relevant to prevention and treatment of a specific molecularly-defined subgroup of OSCC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 8321